In the present study, the frequencies of both CD4+ and CD8+ TCM were significantly lower in ESCC patients treated with CRT compared to the frequency in patients treated with CT (Figure 2a), and NLR was significantly higher in CRT group than CT group (Supplementary Figure S4). This evidence concerns the gene CD8A and esophageal squamous cell carcinoma.